Association of peak expiratory flow rate with clinical outcomes in pulmonary arterial hypertension [0.03%]
峰值呼气流量与肺动脉高压临床结局的关系分析
Kokoro Mitsuyoshi,Kayoko Kubota,Sunao Miyanaga et al.
Kokoro Mitsuyoshi et al.
Pulmonary arterial hypertension (PAH) is a rare disease characterized by a progressive increase in pulmonary arterial pressure, leading to right heart failure. In clinical practice, reduced exercise tolerance is commonly observed in patient...
Prognostic impact of systolic blood pressure and antithrombotic strategy in patients with atrial fibrillation and stable coronary artery disease: a post-hoc analysis of the AFIRE trial [0.03%]
心房颤动和稳定型冠状动脉疾病患者血压及抗栓策略的预后影响：AFIRE试验的事后分析研究
Shinichi Yamanaka,Takashi Noda,Kotaro Nochioka et al.
Shinichi Yamanaka et al.
Backgrounds: The AFIRE (Atrial Fibrillation and Ischemic Events with Rivaroxaban in Patients with Stable Coronary Artery Disease) trial demonstrated that rivaroxaban monotherapy was non-inferior in efficacy and superior i...
From Japan to the world; A new guidelines for hypertension managements from Japanese Society of Hypertension [0.03%]
从日本到世界；日本高血压学会高血压管理新指南
Yusuke Ohya
Yusuke Ohya
Comment on "Lean body mass index and hypertension risk in men: a nationwide epidemiological cohort study" [0.03%]
关于“男性精瘦体重指数与高血压风险的全国流行病学队列研究”的点评
Zhi Wang,Leping Shao
Zhi Wang
Integration of polygenic risk score with measured blood pressure reveals hidden risks of cardiovascular disease mortality: A Japanese prospective cohort study [0.03%]
整合多基因风险评分与测量血压揭示心血管疾病死亡的隐性风险：一项日本前瞻性队列研究
Hiroshi Okumiyama,Ryosuke Fujii,Mako Nagayoshi et al.
Hiroshi Okumiyama et al.
Although previous studies reported that BP PRS is associated with CVD, it is less explored whether BP PRS and BP are jointly associated with CVD, especially among non-European populations. Therefore, we examined joint associations of BP con...
Efficacy and safety of esaxerenone vs trichlormethiazide for the treatment of uncontrolled essential hypertension in Japanese patients with type 2 diabetes mellitus: a subanalysis of the EXCITE-HT study [0.03%]
用于日本2型糖尿病合并难以控制的原发性高血压患者治疗的有效性和安全性：与特拉唑嗪对照评价esaxerenone疗效（EXCITE-Ht研究的事后分析）
Mitsuru Ohishi,Kazuomi Kario,Tomohiro Katsuya et al.
Mitsuru Ohishi et al.
This subgroup analysis of the randomized, open-label, parallel-group EXCITE-HT study explored the antihypertensive efficacy and safety of esaxerenone vs trichlormethiazide in patients with type 2 diabetes mellitus (T2DM), stratified by base...
Subtype specific immune-metabolic reprogramming in preeclampsia revealed by multiomics and serum biomarkers [0.03%]
多组学和血清生物标志物揭示子类型特异性免疫代谢重塑在子痫前期中的作用
Yixuan Chen,Linlin Wu,Dongni Huang et al.
Yixuan Chen et al.
Preeclampsia comprises early-onset (EOPE) and late-onset (LOPE) subtypes with distinct etiologies, placental pathology, and severity, but cellular/metabolic drivers and early biomarkers remain unclear. We integrated placental single-cell RN...
Masaki Mogi
Masaki Mogi